Search
Close this search box.

Atropos Health Partners with Arcadia for Real-World Evidence Access in Healthcare

Atropos Health, a trailblazer in transforming real-world clinical data into personalized evidence, has unveiled its strategic partnership with Arcadia, a leading healthcare data platform.

Atropos Health, a trailblazer in transforming real-world clinical data into personalized evidence, has unveiled its strategic partnership with Arcadia, a leading healthcare data platform. This collaboration integrates Arcadia into Atropos Evidence™ Network, empowering Arcadia’s provider customers with access to Atropos Health’s evidence-generating applications. The partnership aims to foster data-driven clinical decision-making for whole-person care and value-based performance.

Value Proposition for Arcadia Customers

The partnership enables Arcadia’s provider customers subscribing to Atropos Health to accelerate precise clinical decision-making. By leveraging Atropos Health’s evidence-generating applications, healthcare providers can tailor high-value, low-cost care based on individual patient physiology, promoting optimal health outcomes.

Leveraging Real-World Evidence (RWE) for Life Sciences

Life Sciences users of Atropos Health gain access to Arcadia’s longitudinal research dataset within the Atropos Evidence Network. This collaboration empowers Life Sciences users to conduct real-world evidence studies, harnessing Arcadia’s extensive dataset for advanced research and insights generation.

Upskill your Engineering Team with Generative AI

A customized corporate training program on generative AI can upskill and increase your engineering team productivity.

Reserve Your Spot
ADaSci Generative AI Certification Course

Insights from Atropos Health CEO

Dr. Brigham Hyde, CEO and Co-Founder of Atropos Health, emphasized the significance of this collaboration in enhancing clinical decision-making. He highlighted the integration of Arcadia’s quality data into the Atropos Evidence Network, enabling rapid generation of novel, peer-reviewed evidence vital for informed healthcare decisions.

Atropos Health’s Solutions Portfolio

Atropos Health offers a suite of evidence-generation tools, including Geneva OS™, installed within clients’ cloud data environments. The portfolio includes Alexandria™, housing a vast collection of existing studies for rerunning on local data, aiding in novel evidence generation. Additionally, the CRAFT Emulation Toolkit™ facilitates trial recruitment improvement and subgroup analysis within real-world data, influencing diverse trial recruitment strategies.

About Atropos Health

Atropos Health is a pioneering developer of Geneva OS, facilitating rapid healthcare evidence generation across diverse real-world data networks. Their solutions aim to bridge evidence gaps, enhance clinical outcomes, expedite research, and drive data-driven care. With a foundation in peer-reviewed publications and extensive user expertise, Atropos Health strives to revolutionize healthcare through timely, impactful real-world evidence.

Anshika Mathews
Anshika Mathews
Anshika is an Associate Research Analyst working for the AIM Leaders Council. She holds a keen interest in technology and related policy-making and its impact on society. She can be reached at anshika.mathews@aimresearch.co
Meet 100 Most Influential AI Leaders in USA
MachineCon 2024
26th July, 2024, New York
Latest Edition

AIM Research Apr 2024 Edition

Subscribe to our Latest Insights
By clicking the “Continue” button, you are agreeing to the AIM Media Terms of Use and Privacy Policy.
Recognitions & Lists
Discover, Apply, and Contribute on Noteworthy Awards and Surveys from AIM
AIM Leaders Council
An invitation-only forum of senior executives in the Data Science and AI industry.
Stay Current with our In-Depth Insights
Our Upcoming Events
Intimate leadership Gatherings for Groundbreaking Insights in Artificial Intelligence and Analytics.
AIMResearch Event
Supercharge your top goals and objectives to reach new heights of success!

Cutting Edge Analysis and Trends for USA's AI Industry

Subscribe to our Newsletter